Profund Advisors’s Orphazyme A/S ORPH Stock Holding History

Profund Advisors’s Portfolio ORPH Stock Details ORPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-127,524	Closed	-$307K	–	1439
2021 Q4	$307K	Buy	+127,524	New	+$450K	0.01%	966

Other funds holding ORPH

Optiver Holding Amsterdam, Netherlands $371B AUM 64.6% 1-Year Est. Return

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Profund Advisors's ORPH Position: Q1 2022 in Review

Profund Advisors sold out of Orphazyme A/S (ORPH) in Q1 2022, closing a stake of 127,524 shares — an estimated $307K sold.

Profund Advisors first reported a position in ORPH in Q4 2021 and held it in 1 quarter. The position peaked at $307K in Q4 2021. 4 funds tracked by Wall St. Rank hold ORPH as of Q1 2022.

Profund Advisors reported no remaining Orphazyme A/S position as of Q1 2022 after selling out during the quarter.
Profund Advisors sold 127,524 Orphazyme A/S shares in Q1 2022, an estimated $307K.
Profund Advisors first reported a position in Orphazyme A/S in Q4 2021 and held it in 1 quarter.
Profund Advisors's Orphazyme A/S position peaked at $307K in Q4 2021.
4 funds tracked by Wall St. Rank held Orphazyme A/S as of Q1 2022.

Based on Profund Advisors's 13F filing for Q1 2022, filed 10 May 2022.